Literature DB >> 22424123

Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.

Aleksandar Ignjatović1, Zorica Stević, Dragana Lavrnić, Aleksandra Nikolić-Kokić, Duško Blagojević, Mihajlo Spasić, Ivan Spasojević.   

Abstract

ALS is characterized by oxidative damage in the brain and cerebrospinal fluid, which is exerted by pro-oxidative activity of iron. Such activity of iron can be drastically increased in the presence of inappropriate iron ligands that catalyze redox cycling of iron, thereby promoting hydroxyl radical generation. The aim of our study was to determine the relative level of inappropriate iron ligands in the cerebrospinal fluid of ALS patients. To determine the levels of inappropriate iron ligands and redox activity of iron in cerebrospinal fluid (10 samples from ALS patients and 10 controls), we applied electron paramagnetic resonance spectroscopy. We have shown that cerebrospinal fluid of ALS patients comprises two-fold increased level of inappropriate iron ligands, proportionally increasing iron redox activity and hydroxyl radical production compared to controls. In conclusion, our results strongly support the pro-oxidative/detrimental role of inappropriately chelated iron in ALS pathophysiology. The identification of biomolecules that form such iron complexes and their therapeutic targeting may represent the future of ALS treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22424123     DOI: 10.3109/17482968.2012.665929

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  14 in total

1.  A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

Authors:  Sagit Golko-Perez; Tamar Amit; Orit Bar-Am; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2016-11-08       Impact factor: 3.911

Review 2.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

3.  Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.

Authors:  Sagit Golko-Perez; Tamar Amit; Moussa B H Youdim; Orly Weinreb
Journal:  J Mol Neurosci       Date:  2016-05-13       Impact factor: 3.444

Review 4.  Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.

Authors:  Yiyan Sun; Xiaohuan Xia; Diksha Basnet; Jialin C Zheng; Jian Huang; Jianhui Liu
Journal:  Front Aging Neurosci       Date:  2022-06-28       Impact factor: 5.702

Review 5.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

6.  Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Sagit Golko-Perez; Silvia Mandel; Tamar Amit; Lana Kupershmidt; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2015-11-18       Impact factor: 3.911

7.  Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?

Authors:  Caroline Moreau; Véronique Danel; Jean Christophe Devedjian; Guillaume Grolez; Kelly Timmerman; Charlotte Laloux; Maud Petrault; Flore Gouel; Aurélie Jonneaux; Mary Dutheil; Cédrick Lachaud; Renaud Lopes; Grégory Kuchcinski; Florent Auger; Maeva Kyheng; Alain Duhamel; Thierry Pérez; Pierre François Pradat; Hélène Blasco; Charlotte Veyrat-Durebex; Philippe Corcia; Patrick Oeckl; Markus Otto; Luc Dupuis; Guillaume Garçon; Luc Defebvre; Z Ioav Cabantchik; James Duce; Régis Bordet; David Devos
Journal:  Antioxid Redox Signal       Date:  2018-02-08       Impact factor: 8.401

Review 8.  Astrocytes in heavy metal neurotoxicity and neurodegeneration.

Authors:  Baoman Li; Maosheng Xia; Robert Zorec; Vladimir Parpura; Alexei Verkhratsky
Journal:  Brain Res       Date:  2021-01-05       Impact factor: 3.252

Review 9.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

Review 10.  Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders.

Authors:  Hong Cheng; Bobo Yang; Tao Ke; Shaojun Li; Xiaobo Yang; Michael Aschner; Pan Chen
Journal:  Toxics       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.